These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3828194)

  • 1. Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.
    Canepa-Anson R; Dawson JR; Kuan P; Poole-Wilson PA; Sutton GC; Cockrill B; Reuben SR
    Br J Clin Pharmacol; 1987 Feb; 23(2):173-81. PubMed ID: 3828194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study.
    Timmis AD; Bergman G; Walker L; Monaghan MJ; Jewitt DE
    Int J Cardiol; 1984 Mar; 5(3):327-38. PubMed ID: 6706438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
    Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
    Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the beta-adrenergic receptor agonist pirbuterol on cardiac performance during acute ischaemic left ventricular failure in dogs.
    Smiseth OA
    Eur J Pharmacol; 1983 Mar; 87(4):379-86. PubMed ID: 6133759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
    Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
    Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
    Uretsky BF; Seecof RM; Reddy PS
    Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
    Weber RW; Nelson HS
    Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
    Biernacki W; Prince K; Whyte K; MacNee W; Flenley DC
    Am Rev Respir Dis; 1989 Feb; 139(2):492-7. PubMed ID: 2563321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
    Dawson JR; Canepa-Anson R; Kuan P; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Heart J; 1983 Sep; 50(3):282-9. PubMed ID: 6137226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
    Weber KT; Andrews V; Janicki JS; Likoff M; Reichek N
    Circulation; 1982 Dec; 66(6):1262-7. PubMed ID: 6128086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term hemodynamic effects of oral pirbuterol in patients with chronic severe congestive heart failure: randomized double-blind trial.
    Pamelia FX; Gheorghiade M; Beller GA; Bishop HL; Olukotun AY; Taylor CR; Watson DD; Grunwald AM; Sirowatka J; Carabello BA
    Am Heart J; 1983 Dec; 106(6):1369-76. PubMed ID: 6359846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.
    MacNee W; Wathen CG; Hannan WJ; Flenley DC; Muir AL
    Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1169-72. PubMed ID: 6138118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure.
    Colucci WS; Alexander RW; Mudge GH; Rude RE; Holman BL; Wynne J; Grossman W; Braunwald E
    Am Heart J; 1981 Sep; 102(3 Pt 2):564-8. PubMed ID: 6115573
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
    Awan NA; Needham K; Evenson MK; Hermanovich J; Joye JA; DeMaria AN; Mason DT
    Am Heart J; 1981 Sep; 102(3 Pt 2):555-63. PubMed ID: 7270402
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of severe chronic CHF with oral pirbuterol.
    Awan NA; Needham K; Evenson MK; Mason DT
    Acta Med Scand Suppl; 1981; 652():155-62. PubMed ID: 6949462
    [No Abstract]   [Full Text] [Related]  

  • 19. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
    Nelson GI; Silke B; Barker MC; Saxton CA; Taylor SH
    Eur Heart J; 1982 Jun; 3(3):238-45. PubMed ID: 6125392
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ; Tashkin DP; Ho D; Child JS
    Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.